Stay updated on Autologous TILs in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Autologous TILs in Metastatic TNBC Clinical Trial page.

Latest updates to the Autologous TILs in Metastatic TNBC Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.1 instead of v3.8.0.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page displays the completed Phase 2 study record for autologous LN-145 tumor-infiltrating lymphocyte therapy in pretreated metastatic triple-negative breast cancer, including its criteria, outcomes, and protocol document.SummaryDifference48%

- Check18 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check32 days agoChange DetectedA site-wide NIH banner was added with an announcement about terminology for artificial intelligence, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check46 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe study page for NCT04111510 now shows a 403 Forbidden error, replacing the usual study content with a generic error page. As a result, access to the study details, documents, and related information is blocked on this page.SummaryDifference18%

Stay in the know with updates to Autologous TILs in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TILs in Metastatic TNBC Clinical Trial page.